Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Z Potter

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Archives of General Psychiatry|January 1, 1992
Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorderS E Swedo, H L Leonard, M J Kruesi, et al.
Archives of Neurology|August 1, 1985
Evaluation of zimeldine in Alzheimer's disease. Cognitive and biochemical measuresN R Cutler, J Haxby, A D Kay, et al.
The Journal of Clinical Psychiatry|September 1, 1995
Bupropion: a review of its mechanism of antidepressant activityJ A Ascher, J O Cole, J N Colin, et al.
The American Journal of Psychiatry|January 1, 1997
Cerebrospinal fluid monoamine metabolites in childhood-onset schizophreniaL K Jacobsen, J A Frazier, A K Malhotra, et al.
Archives of Neurology|April 1, 1997
Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer diseaseN C Bodick, W W Offen, A I Levey, et al.
Neurology|December 24, 2010
Report of the task force on designing clinical trials in early (predementia) ADP S Aisen, S Andrieu, C Sampaio, et al.
Schizophrenia Research|March 15, 2023
Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteersM Cecchi, M Adachi, A Basile, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Archives of General Psychiatry|January 1, 1992
Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorderS E Swedo, H L Leonard, M J Kruesi, et al.
Archives of Neurology|August 1, 1985
Evaluation of zimeldine in Alzheimer's disease. Cognitive and biochemical measuresN R Cutler, J Haxby, A D Kay, et al.
The Journal of Clinical Psychiatry|September 1, 1995
Bupropion: a review of its mechanism of antidepressant activityJ A Ascher, J O Cole, J N Colin, et al.
The American Journal of Psychiatry|January 1, 1997
Cerebrospinal fluid monoamine metabolites in childhood-onset schizophreniaL K Jacobsen, J A Frazier, A K Malhotra, et al.
Archives of Neurology|April 1, 1997
Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer diseaseN C Bodick, W W Offen, A I Levey, et al.
Neurology|December 24, 2010
Report of the task force on designing clinical trials in early (predementia) ADP S Aisen, S Andrieu, C Sampaio, et al.
Schizophrenia Research|March 15, 2023
Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteersM Cecchi, M Adachi, A Basile, et al.
Pageof 17